XML 22 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 52,548 $ 18,142
Investments 79,555 0
Prepaid expenses and other assets 2,505 813
Total current assets 134,608 18,955
Property and equipment, net 976 985
Goodwill 30,815 0
Restricted cash 1,644 207
Deposits 168 0
Investments 39,363 0
Total assets 207,574 20,147
Current liabilities:    
Accounts payable and accrued expenses 8,285 2,062
Accrued research and development costs 1,861 2,459
Total current liabilities 10,146 4,521
Convertible notes, net of unamortized discount 39,842 0
Deferred rent and lease obligations 510 107
Total liabilities 50,498 4,628
Commitments and contingencies (Note 12)
Shareholders' equity:    
Common stock, $0.01 par value, 120,000,000 shares authorized; 39,506,527 and 6,795,627 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively 395 1
Additional paid-in capital 219,225 5,407
Accumulated other comprehensive loss (79) 0
Accumulated deficit (62,465) (31,355)
Total shareholders' equity 157,076 15,519
Total liabilities and shareholders' equity 207,574 20,147
Series A Convertible Preferred Shares [Member]    
Shareholders' equity:    
Preferred shares 0 16,060
Series B Convertible Preferred Shares [Member]    
Shareholders' equity:    
Preferred shares $ 0 $ 25,406